For the first time, scientists have developed 3D brain models using cells from multiple individuals, called "chimeroids." These hybrid brain organoids better mimic human biology and genetic diversity, promising to accelerate drug research and development. The innovative method could enhance early-stage drug testing and advance treatments for neurological diseases.